HOUSTON--(BUSINESS WIRE)--Positron Corporation (OTC:POSC) and Disease Management, LLC have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.
The product will include a heart disease pre-test risk calculator, a Coronary Disease Reversal and Prevention practice management program, a web-based, patient centric, disease reversal and life style modification program, an interpreting and referring physician portal, as well as a cost efficacy and patient outcomes tracker.
The product will include a heart disease pre-test risk calculator, a Coronary Disease Reversal and Prevention practice management program, a web-based, patient centric, disease reversal and life style modification program, an interpreting and referring physician portal, as well as a cost efficacy and patient outcomes tracker.
